Skip to main content

Advertisement

SpringerLink
Log in

Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

We investigated the effects of FK228 on cell proliferation and apoptosis against human glioblastoma (GM) T98G, U251MG, and U87MG cells. Upon exposure to FK228, cell proliferation was inhibited, and apoptosis detected by the cleavage of CPP32 was induced. FK228 increased the expression levels of p21 (WAF-1) and of pro-apoptotic Bad protein in all GM cells. Furthermore, FK228 treatment also reduced the anti-apoptotic protein Bcl-xL in all GM cells and anti-apoptotic Bcl-2 in U87MG cells, thereby shifting the cellular equilibrium from life to death. An increased accumulation of histone H4 was detected in the p21 (WAF-1) promoter and the structural gene (exon 2) and the Bad structural gene (exon 2 and 3) upon treatment with FK228, as assessed by chromatin immunoprecipitation (ChIP) assay. Thus, the results indicated that an increased expression of p21 (WAF1) and Bad due to FK228 is regulated, at least in part, by the degree of acetylation of the gene-associated histone. We also found that FK228 inhibits cellular invasiveness and decreases MMP-2 activity. In addition, the growth of transplanted human GM m-3 cells into the subcutaneous tissue of hereditary athymic mice was significantly inhibited, and apoptosis was induced with FK228 treatment. The results suggested that FK228 might be useful in the treatment of human GM, although further studies will be needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3a
Fig. 4a,b
Fig. 5a
Fig. 6a–d
Fig. 7a–c

Similar content being viewed by others

References

  1. Choi JH, Kwon HJ, Yoon BI, Kim JH, Han SU, Joo HJ, Kim DY (2001) Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res 92:1300–1304

    CAS  PubMed  Google Scholar 

  2. Farrow SN, Brown R (1996) New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev 6:45–49

    CAS  PubMed  Google Scholar 

  3. Fecteau KA, Mei J, Wang HC (2002) Differential modulation of signaling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228. J Pharmacol Exp Ther 300:890–899

    Article  CAS  PubMed  Google Scholar 

  4. Hara I, Miyake H, Hara S, Arakawa S, Kamidono S (2000) Sodium butyrate induces apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-Fas-mediated cytotoxicity. Int J Oncol 17:1212–1218

    Google Scholar 

  5. Ito N, Sawa H, Nagane M, Noguchi A, Hara M, Saito I (2001) Inhibitory effects of sodium butyrate on proliferation and invasiveness of human glioma cells. Neurosurgery 49:430–437

    CAS  PubMed  Google Scholar 

  6. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW, Kim KW (2001) Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7:437–443

    PubMed  Google Scholar 

  7. Kosugi H, Ito M, Yamamoto Y, Towatari M, Ito M, Ueda R, Saito H, Naoe T (2001) In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice. Jpn J Cancer Res 92:529–536

    CAS  PubMed  Google Scholar 

  8. Kuo MH, Allis CD (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20:615–626

    Article  CAS  PubMed  Google Scholar 

  9. Kwon HJ, Kim MS, Kim MJ, Nakajima H, Kim KW (2002) Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis. Int J Cancer 97:290–296

    CAS  PubMed  Google Scholar 

  10. Liu LT, Chang HC, Chiang LC, Hung WC (2003) Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 63:3069–3072

    CAS  PubMed  Google Scholar 

  11. Miyake H, Hara S, Arakawa S, Kamidono S, Hara I (2001) Overexpression of Bcl-2 regulates sodium butyrate- and/or docetaxel-induced apoptosis in human bladder cancer cells both in vitro and in vivo. Int J Cancer 93:26–32

    Article  CAS  PubMed  Google Scholar 

  12. Murata M, Towatari M, Kosugi H, Tanimoto M, Ueda R, Saito H, Naoe T (2000) Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells. Jpn J Cancer Res 91:1154–1160

    CAS  PubMed  Google Scholar 

  13. Nakajima H, Kim YB, Terano H, Yoshida M, Horinouchi S (1998) FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp Cell Res 241:126–133

    Article  CAS  PubMed  Google Scholar 

  14. Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ (1990) Influence of organ environment on extracellular-matrix-degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82:1890–1898

    CAS  PubMed  Google Scholar 

  15. Narlikar GJ, Fan HY, Kingston RE (2002) Cooperation between complexes that regulate chromatin structure and transcription. Cell 108:475–487

    CAS  PubMed  Google Scholar 

  16. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619

    CAS  PubMed  Google Scholar 

  17. Rajgolikar G, Chan KK, Wang HC (1998) Effects of a novel antitumor depsipeptide, FR901228, on human breast cancer cells. Breast Cancer Res Treat. 51:29–38

    Google Scholar 

  18. Richon VM, Sandhoff TW, Rifkind RA, Marks PA (2000) Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 97:10014–10019

    Article  CAS  PubMed  Google Scholar 

  19. Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E, Seidman EG (1999) Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ 6:729–735

    Article  CAS  Google Scholar 

  20. Sandor V, Senderowicz A, Mertins S, Sackett D, Sausville E, Blagosklonny MV, Bates SE (2000) P21-dependent g(1) arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228. Br J Cancer 83:817–825

    Article  CAS  PubMed  Google Scholar 

  21. Sawa H, Murakami H, Ohshima Y, Sugino T, Nakajyo T, Kisanuki T, Tamura Y, Satone A, Ide W, Hashimoto I, Kamada H (2001) Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. Brain Tumor Pathol 18:109–114

    CAS  PubMed  Google Scholar 

  22. Sawa H, Murakami H, Ohshima Y, Murakami M, Yamazaki I, Tamura Y, Mima T, Satone A, Ide W, Hashimoto I, Kamada H (2002) Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol 19:77–81

    CAS  PubMed  Google Scholar 

  23. Sugawa N, Yamamoto K, Ueda S, Morita N, Kita M, Nishino H, Fushiki S, Okabe T (1998) Function of aberrant EGFR in malignant gliomas. Brain Tumor Pathol 15:53–57

    CAS  PubMed  Google Scholar 

  24. Tsai LC, Hung MW, Chang GG, Chang TC (2000) Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. Anticancer Res 20:2441–2448

    CAS  PubMed  Google Scholar 

  25. Ueda H, Nakajima H, Hori Y, Goto T, Okuhara M (1994) Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells. Biosci Biotechnol Biochem 58:1579–1583

    CAS  PubMed  Google Scholar 

  26. Vigushin DM, Coombes RC (2002) Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13:1–13

    Article  CAS  PubMed  Google Scholar 

  27. Weiser TS, Ohnmacht GA, Guo ZS, Fischette MR, Chen GA, Hong JA, Nguyen DM, Schrump DS (2001) Induction of MAGE-3 expression in lung and esophageal cancer cells. Ann Thorac Surg 71:295–301

    Article  CAS  PubMed  Google Scholar 

  28. Yu X, Guo ZS, Marcu MG, Neckers L, Nguyen DM, Chen GA, Schrump DS (2002) Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J Natl Cancer Inst 94:504–513

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

We are grateful to Fujisawa Pharmaceutical Co., Ltd. for providing FK228.

Author information

Authors and Affiliations

  1. Oncology Research Center, Hokuto Hospital, Kisen 7-5, Inada-cho, 080-0833, Obihiro, Hokkaido, Japan

    Hiroki Sawa, Hiromi Murakami & Masaoki Kumagai

  2. Department of Neurosurgery, Hokuto Hospital, 080-0833, Obihiro, Hokkaido, Japan

    Hiroki Sawa, Matsuyoshi Nakasato, Shigeru Yamauchi, Nozomu Matsuyama, Yasuo Tamura, Akira Satone, Wataru Ide, Ikuo Hashimoto & Hajime Kamada

Authors
  1. Hiroki Sawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiromi Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaoki Kumagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matsuyoshi Nakasato
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shigeru Yamauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nozomu Matsuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yasuo Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Akira Satone
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wataru Ide
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ikuo Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hajime Kamada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroki Sawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sawa, H., Murakami, H., Kumagai, M. et al. Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo. Acta Neuropathol 107, 523–531 (2004). https://doi.org/10.1007/s00401-004-0841-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-004-0841-3

Keywords

Search

Navigation